How does Retevmo work?

Retevmo is a selective RET kinase inhibitor that blocks certain enzymes to slow the growth of cancers caused by abnormal RET genes. Blocking RET in cancer tumors can slow cancer growth. Patients are selected for treatment with Retevmo based on a specific biomarker test approved by the FDA.

Retevmo is considered a targeted drug therapy that blocks specific pathways that allow cancer to grow uncontrolled. It is used in locally advanced cancer that has spread to nearby tissue or lymph nodes, and advanced or metastatic cancer that has spread to other places or organs in the body. Advanced and metastatic cancer is less likely to be cured, but may be slowed with treatment and lengthen survival in some people.

Retevmo is used to treat:

• RET (rearranged during transfection) gene fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults.
• Advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation in adults and children 2 years and older who require systemic (body-wide) therapy.
• Advanced or metastatic thyroid cancer with a RET gene fusion in adults and children 2 years and older who require systemic (body-wide) therapy and who have received radioactive iodine and it did not work or is no longer working (if radioactive iodine is appropriate).
• Locally advanced or metastatic solid tumors with a RET gene fusion in adults and children 2 years and older that have progressed on or following prior systemic (body-wide) treatment or who have no satisfactory alternative treatment options. The most common solid tumors in studies were pancreatic cancer (27%), colon cancer (24%), salivary gland cancer (10%) and unknown primary site (7%).

The indication for locally advanced or metastatic solid tumors is approved under FDA-accelerated approval based on overall response rate and duration of response. Continued approval may depend upon proven clinical benefit in further confirmatory trials.

What is the mechanism of action for Retvmo?

The mechanism of action of Retevmo involves turning off the production of RET in RET-driven cancers. Abnormal alterations in genes can cause cancer growth. One gene that may change is called RET (rearranged during transfection) and it has been identified in certain types of cancer.

RET is normally used to help our cells to talk to each other (called “cell signaling") to ensure healthy cell functioning, but if you have a gene change, RET can be activated non-stop to lead to uncontrolled cancer cell growth. Blocking RET in cancer tumors can slow cancer growth.

RET genes in cancer can fuse to another gene and this is called RET fusion. RET can be found in lung cancer, thyroid tumors and other solid cancers (such as pancreatic cancer, colon cancer, and breast cancer).

Is Retevmo a chemotherapy drug?

No, Retevmo is considered a targeted drug therapy, not a traditional chemotherapy agent. It is given by mouth as an oral capsule or tablet, not through a vein.

Targeted drug therapy like Retevmo works by blocking specific pathways that allow the cancer to grow uncontrolled. Targeted drug therapies find and attack specific types of cancer cells and may cause less damage to healthy cells; however, common and serious side effects may still occur, even to healthy cells.

Chemotherapy works by killing rapidly growing cancer cells, but can also adversely affect normal cells.

Retevmo may cause serious side effects, such as severe or life-threatening problems with your lungs (inflammation / swelling), liver, heart, thyroid or other body systems. It can cause problems with high blood pressure, heart rhythm changes, would healing, or bleeding. Serious allergic reactions can also occur.

Related questions

• What is the strongest chemotherapy drug for breast cancer?
• Which medications make you sleepy?
• Is small cell or non-small cell lung cancer worse?

Common side effects in adults

Common side effects with Retevmo in at least 25% of adults patients with solid tumors include: fluid retention (swelling or edema), diarrhea, fatigue (tiredness), dry mouth, high blood pressure (hypertension), stomach area (abdominal) pain, constipation, rash, nausea, and headache.

Laboratory changes (grade 3 or 4) in at least 5% of adults with solid tumors include: decreased lymphocytes (white blood cells that help fight infection), increased alanine aminotransferase (ALT, a liver enzyme), increased aspartate aminotransferase (AST, a liver enzyme), decreased sodium and decreased calcium.

Common side effects in children

The most common adverse reactions in at least 25% of children with solid tumors include: musculoskeletal (muscle or bone) pain, diarrhea, headache, nausea, vomiting, coronavirus infection (COVID-19), abdominal (stomach) pain, fatigue (tiredness), pyrexia (fever), and hemorrhage (bleeding).

Laboratory changes (grade 3 or 4) in at least 5% of children with solid tumors include decreased calcium, decreased hemoglobin (oxygen-carry protein your red blood cells), and decreased neutrophils (a type of white blood cell that helps to fight infection).

Your doctor or pharmacist should give you a handout to learn how to recognize Retevmo side effects and when you should call your doctor. If you do not have one, ask them for a copy.

This is not a complete list of side effects. Talk to your doctor about what you should expect for side effects during treatment.

Learn More: Side Effects and Warnings for Retevmo

How do I take Retvmo?

Retevmo is given as an oral capsule or tablet taken twice daily (approximately every 12 hours) until your disease worsens or you experience intolerable side effects. You can take it with or without food. Swallow your medicine whole, do not crush or chew it.

Your doctor will determine your dose, which is based on your weight. Always take your medicine exactly as your doctor prescribes it.

The generic name for Retevmo (pronounced reh-TEHV-moh) is selpercatinib. It is manufactured by Eli Lilly and was first approved in May 2020.

This is not all the information you need to know about Retevmo for safe and effective use and does not take the place of your doctor’s directions. Review the full Retevmo product information and discuss any questions you have with your doctor or other health care provider.

Read next

See also:

Related medical questions

• What type of prostate cancer is Erleada used to treat?
• What type of lung cancer is Vizimpro used to treat?
• What type of cancer is Tecentriq used to treat?
• What type of cancer is Daurismo (glasdegib) used to treat?
• Oxycodone vs Hydrocodone - How do they compare?
• Does methylene blue kill cancer cells​?
• Does omeprazole cause cancer?
• Why is Xanax so addictive?
• Does Ozempic cause cancer?
• How do you increase platelet count during chemotherapy?
• What is CAR T-cell therapy and how does it work?
• What are Monoclonal Antibodies and how do they work?
• Radiation vs. Chemo: Which cancer treatment is right for you?
• Vicodin vs Percocet: What's the difference?
• What medications are known to cause hair loss?
• What is Quercetin and what are its health benefits?
• Why give Taxol (Paxel) before carboplatin?
• What is the TC chemo regimen and how does it treat breast cancer?
• How do I know if immunotherapy is working?
• What are anti-VEGF drugs (VEGF inhibitors)?
• Treatments for Menopause
• My stool has changed color. What does it mean?
• How do I know if Aldara is working for skin cancer?
• How is Keytruda used for lung cancer?

Drug information

• Retevmo Information for Consumers
• Retevmo prescribing info & package insert (for Health Professionals)
• Side Effects of Retevmo (detailed)
• Retevmo user reviews (4)

Related support groups

• Retevmo (1 questions, 3 members)
• Cancer (196 questions, 645 members)
• Thyroid Cancer (14 questions, 44 members)
• Non-Small Cell Lung Cancer (53 questions, 73 members)
• Solid Tumors (4 questions, 7 members)

Medical Disclaimer